Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.428
Filter
1.
S D Med ; 77(6): 274-279, 2024 Jun.
Article in English | MEDLINE | ID: mdl-39013101

ABSTRACT

Raoultella planticola is a Gram-negative, aerobic, nonmotile bacterium that is ubiquitous in the environment usually implicated in opportunistic infections. There have been very few reported cases of Raoultella planticola infection in the pediatric population. Most of these reports have been in cases of neonatal septicemia. This case report describes a case of a 3-day-old Hispanic full-term male that presented with recalcitrant hyperbilirubinemia despite maximal phototherapy found to have urinary tract infection with Raoultella planticola on multiple cultures. The patient's hyperbilirubinemia appropriately responded to treatment of the UTI. This report highlights that, albeit rare, neonatal UTI can present as recalcitrant hyperbilirubinemia. Raoultella planticola is a rare organism that is normally found in the environment but may be a bona fide etiologic agent in neonatal UTI.


Subject(s)
Enterobacteriaceae Infections , Urinary Tract Infections , Humans , Urinary Tract Infections/diagnosis , Urinary Tract Infections/microbiology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/complications , Male , Infant, Newborn , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/isolation & purification , Hyperbilirubinemia , Anti-Bacterial Agents/therapeutic use
2.
Expert Rev Mol Diagn ; 24(7): 583-590, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39054637

ABSTRACT

INTRODUCTION: Carbapenem-resistant Enterobacterales (CRE) causing severe infections in humans have represented an important challenge for clinicians worldwide during the past two decades. AREAS COVERED: Novel ß-lactams and ß-lactam/ß-lactamase inhibitor combinations have led to a shift in the first-line approach to the treatment of severe CRE infections from polymyxin-based regimens to treatment with less toxic agents. This new scenario offers the opportunity to apply rapid molecular diagnostic tests for CRE infection to identify different types of carbapenemases. Herein, the authors provide an overview of this subject and follow it with their expert perspectives. EXPERT OPINION: When considering studies actually measuring the clinical impact of rapid molecular tests in real-life scenarios, high certainty evidence from randomized controlled trials is still limited and not focused on CRE infections. Nonetheless, it is indisputable that rapid molecular tests have been shown to impact early therapeutic choices (in terms of both escalation and de-escalation) when used in real-life settings, thus issues in the clinical interpretation of their results are already relevant. Overall, increased expertise is required for the appropriate interpretation of rapid molecular tests for personalized antibiotic selection by understanding their strengths and limitations.


Subject(s)
Anti-Bacterial Agents , Carbapenem-Resistant Enterobacteriaceae , Enterobacteriaceae Infections , Molecular Diagnostic Techniques , Humans , Molecular Diagnostic Techniques/methods , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/microbiology , Carbapenem-Resistant Enterobacteriaceae/drug effects , Carbapenem-Resistant Enterobacteriaceae/genetics , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , beta-Lactamases/metabolism , beta-Lactamases/genetics , Carbapenems/therapeutic use , Carbapenems/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Microbial Sensitivity Tests/methods
3.
J Microbiol Methods ; 224: 107003, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39038560

ABSTRACT

The reduction of antimicrobial susceptibility testing (AST) time-to-result is a central need, especially in sepsis treatment. The current automated rapid ASTs are still too expensive for many laboratories. We aimed to evaluate three pre-treatment methods for a same-day inoculation on both automated AST platforms available in our laboratory. We tested 100 Enterobacterales or staphylococci positive bottles. We obtained good results with the different methods and instruments. In particular, Vitek-2 showed good performances with Enterobacterales AST when inoculated with bacterial pellet (96.6% categorical agreement - CA-, 93.3% essential agreement - EA). Also short-term incubation colonies for staphylococci AST had acceptable CA (94.2%), even if with 77.5% EA. MicroScan system for staphylococci AST with both short-term incubation and direct blood inoculation reached >95% CA, but 92.5% and 83.6% EA, respectively. On the other hand, Enterobacterales AST showed optimal performances only with bacterial pellet inoculation (97.6% CA). In fact, direct blood inoculation showed not acceptable parameters for several molecules. Both systems allow a 24-h reduction in time-to-result, by using the same instruments of routine activity after rapid and cheap pre-treatments.


Subject(s)
Blood Culture , Enterobacteriaceae , Microbial Sensitivity Tests , Staphylococcus , Humans , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Blood Culture/methods , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/instrumentation , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Anti-Bacterial Agents/pharmacology , Cost-Benefit Analysis , Time Factors , Staphylococcal Infections/microbiology , Staphylococcal Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis
4.
Future Microbiol ; 19(12): 1049-1054, 2024 Aug 12.
Article in English | MEDLINE | ID: mdl-39016073

ABSTRACT

We report a case of Vandammella animalimorsus in an adult female patient following a cat scratch/bite. Animal bite/scratches may lead to zoonotic transmission of bacteria that subsequently lead to infection. Wound management and antimicrobial therapy is often necessary. The organism was initially misidentified as Neisseria animaloris/zoodegmatis and highlights the difficulty of correctly identifying some bacteria in clinical microbiology laboratories.


Dogs and cats carry bacteria that are not carried in humans. Dog and cat bites or scratches may lead to these bacteria being spread to humans. This can lead to infection. These infections are usually treated by wound care and antibiotics. We describe a case of infection in a human with a bacteria from a cat following a cat bite/scratch to the patient's leg and discuss how the infection was diagnosed and treated.


Subject(s)
Bites and Stings , Female , Animals , Cats , Humans , Bites and Stings/microbiology , Bites and Stings/complications , Anti-Bacterial Agents/therapeutic use , Leg/pathology , Leg/microbiology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae/isolation & purification , Adult
5.
Microbiol Spectr ; 12(7): e0038624, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38832776

ABSTRACT

Rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) is urgently needed to prevent their spread in healthcare settings. Here, we have evaluated the performance of the phenotypic methods for detection of carbapenemase production directly from bacterial cultures. A total of 99 clinical and rectal Enterobacteriaceae isolates were included (81 carrying known carbapenemase-encoding genes and 18 without carbapenemase production). All isolates were subjected to the five phenotypic tests including in-house Carba NP (iCarba NP), modified-Carba NP, E-Test MBL, modified Hodge test (MHT), and commercial combination disk test. Test results were read at different time points for iCarba NP and modified-Carba (1 min, 5 min, 15 min, 1 h and 2 h). The sensitivity and specificity of the iCarba NP were 78.87% and 100%, respectively, whereas those of the modified-Carba NP test were 95.06% and 94.44%, respectively. False-negative results were detected in four OXA-48 isolates with the use of modified-Carba NP, whereas one non-carbapenemase isolate had false-positive results. The sensitivity/specificity was 91.30%/100% and 80.25%/83.33% for the E-Test MBL and MHT, respectively. The sensitivity and specificity of the aminophenylboronic acid synergy test were 100% and 97.94%, respectively, whereas those of the dipicolinic acid synergy test were 82.61% and 96.23%, respectively. Rapid, simple, and reliable methods are needed for laboratory detection of CPE isolates to improve the detection and surveillance of these clinically relevant pathogens in an epidemiological context. We conclude that the modified-Carba NP test can be one of the reliable tests for the prediction of carbapenemase-producing bacteria.IMPORTANCEThe emergence of carbapenem resistance among Gram-negative bacteria is a serious global health threat. Here, we investigate the performance of the five phenotypic assays against carbapenemase-producing and carbapenemase-non-producing Enterobacteriaceae. Accurate and rapid detection of CPE isolates is critically required for clinical management and treatment of infections caused by these organisms. Among the five evaluated phenotypic tests, the mCNP test presented the highest sensitivity (95.06%) and, therefore, can be considered the best test to be used as a screening phenotypic methodology.


Subject(s)
Bacterial Proteins , Carbapenem-Resistant Enterobacteriaceae , Enterobacteriaceae Infections , Sensitivity and Specificity , beta-Lactamases , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , beta-Lactamases/genetics , beta-Lactamases/metabolism , Humans , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Carbapenem-Resistant Enterobacteriaceae/enzymology , Carbapenem-Resistant Enterobacteriaceae/genetics , Microbial Sensitivity Tests , Phenotype , Anti-Bacterial Agents/pharmacology , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/genetics
6.
Clin Lab ; 70(6)2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38868883

ABSTRACT

BACKGROUND: Antibiotic resistance is a major problem threatening human beings. The genetic determinants that carry resistance genes can be transmitted in several ways in clinical and food environments. Hence, this research study aimed to investigate the presence of New Delhi metallo-beta-lactamase-1 (blaNDM-1) produced by enterotoxigenic Enterobacter cloacae in both clinical and food samples. METHODS AND RESULTS: Twenty-four isolates of Enterobacter spp. were isolated, seven isolates from food samples and 17 isolates from blood taken from neonates and children (1 day - 10 years old) resident in a children's hospital. Antibiotic susceptibility test to 14 antibiotics was performed for all isolates. Enterotoxigenicity of the clinical and foodborne isolates was detected phenotypically using Suckling mouse bioassay. Genomic deoxyribonucleic acid (DNA) was extracted from the isolated Enterobacter spp. that were detected resistant to imipenem. Polymerase chain reaction (PCR) was used to amplify blaNDM-1 gene followed by sequencing. The results of the bioassay revealed that 64.28% of E. cloacae ssp. cloacae isolates were enterotoxigenic. Two E. cloacae ssp. cloacae were imipenem resistant. CONCLUSIONS: This study showed that one isolate from a male child 1 < year was bla NDM-1 positive that was con-firmed by sequencing. This is the first report that revealed blaNDM-1 producing Enterobacter cloacae in Iraq.


Subject(s)
Anti-Bacterial Agents , Enterobacter cloacae , Enterobacteriaceae Infections , Microbial Sensitivity Tests , beta-Lactamases , beta-Lactamases/genetics , Enterobacter cloacae/genetics , Enterobacter cloacae/isolation & purification , Enterobacter cloacae/drug effects , Enterobacter cloacae/enzymology , Humans , Infant , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Child , Child, Preschool , Anti-Bacterial Agents/pharmacology , Animals , Infant, Newborn , Iraq , Food Microbiology , Mice
7.
BMJ Case Rep ; 17(6)2024 Jun 06.
Article in English | MEDLINE | ID: mdl-38844354

ABSTRACT

Enteric gram-negative bacteria-associated peritoneal dialysis (PD) peritonitis is common. These organisms are such as Escherichia coli, Klebsiella and Enterobacter species. Pantoea dispersa belongs to the order Enterobacterales, it has known benefits and a role in agricultural and environmental biotechnology. Pantoea dispersa, although still relatively rare, is being increasingly recognised to cause human infections. We are reporting a case of PD peritonitis caused by Pantoea dispersa in a kidney failure patient on continuous ambulatory peritoneal dialysis (CAPD). His peritonitis was treated well with intraperitoneal antibiotics and the patient can resume his CAPD therapy. The increasing reports of Pantoea dispersa-related human infections warrant concerns, both in immunocompromised and immunocompetent patients.


Subject(s)
Anti-Bacterial Agents , Catheter-Related Infections , Enterobacteriaceae Infections , Pantoea , Peritoneal Dialysis, Continuous Ambulatory , Peritonitis , Humans , Pantoea/isolation & purification , Male , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/microbiology , Peritonitis/drug therapy , Peritonitis/etiology , Peritonitis/diagnosis , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Catheter-Related Infections/microbiology , Catheter-Related Infections/drug therapy , Catheter-Related Infections/diagnosis , Anti-Bacterial Agents/therapeutic use , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Middle Aged
8.
Am J Infect Control ; 52(8): 981-983, 2024 08.
Article in English | MEDLINE | ID: mdl-38761851

ABSTRACT

Candida auris is a multidrug-resistant fungal pathogen that is associated with nosocomial outbreaks in patients with extensive health care exposure and treatment outside the United States. The Ohio Department of Health recommends C auris screening in high-risk patients. However, this can be operationally difficult for many health care facilities. This report describes a C auris and carbapenem-resistant Enterobacterales inpatient screening program done in collaboration with state public health.


Subject(s)
Candida auris , Candidiasis , Cross Infection , Inpatients , Humans , Candidiasis/drug therapy , Candidiasis/diagnosis , Candidiasis/microbiology , Ohio , Cross Infection/microbiology , Candida auris/drug effects , Mass Screening/methods , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology
9.
Eur J Clin Microbiol Infect Dis ; 43(7): 1407-1417, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38733425

ABSTRACT

PURPOSE: To evaluate the performance of the rapid colorimetric polymyxin B microelution (RCPEm) in determining polymyxin B resistance directly from Enterobacterales-positive blood cultures. METHODS: A set volume of positive blood culture bottles (diluted 1:10) was inoculated into a glucose-broth-phenol red solution (NP solution), where a polymyxin B disk was previously eluted (final concentration of 3 µg/mL). Test was read each 1 h for up to 4 h. Color change from red/orange to yellow indicated resistant isolates. Results were compared to the reference method, broth microdilution (BMD), performed from colonies grown on solid media from the same blood culture bottle. RESULTS: One hundred fifty-two Enterobacterales-positive blood cultures were evaluated, 22.4% (34/152) of them resistant to polymyxin B (including 6.6% with borderline MICs). When performing directly from positive blood cultures (RCPEm-BC), specificity and sensitivity were 99.1% and 94.1%, respectively. Of note, 79.4% (27/34) of truly resistant isolates required 3 h of incubation, compared to the 18 ± 2 h incubation that microtiter plates of BMD demand before reading can be performed. CONCLUSIONS: RCPEm directly from blood cultures has great potential to be part of the routine of clinical microbiology laboratories to establish polymyxin B susceptibility, impacting outcome of patients with bloodstream infections caused by carbapenem-resistant Enterobacterales.


Subject(s)
Anti-Bacterial Agents , Blood Culture , Colorimetry , Microbial Sensitivity Tests , Polymyxin B , Polymyxin B/pharmacology , Humans , Colorimetry/methods , Microbial Sensitivity Tests/methods , Anti-Bacterial Agents/pharmacology , Blood Culture/methods , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Sensitivity and Specificity , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Drug Resistance, Bacterial , Bacteremia/microbiology , Bacteremia/diagnosis
10.
R I Med J (2013) ; 107(6): 7-9, 2024 Jun 03.
Article in English | MEDLINE | ID: mdl-38810006

ABSTRACT

Raoultella ornithinolytica is a rare, gram-negative environmental enterobacterium. Although infections in humans caused by R. ornithinolytica are uncommon, there are increasing reports implicating it in urinary tract infections, hepatobiliary infections, and bacteremia, designating it as an emerging pathogen. Its habitat is primarily in aquatic environments and soil, with seafood frequently identified as a potential source of infection. While these infections have predominantly been described in immunocompromised patients previously, our case suggests that advanced age may be a significant risk factor. We describe a case of a 73-year-old man presenting with encephalopathy who then was found to have R. ornithinolytica bacteremia from a genitourinary source. Following antibiotic treatment, the infection resolved and the neurologic symptoms improved. To the best of our knowledge, this is the first documented case in the medical literature of R. ornithinolytica featuring a primary neurologic presentation.


Subject(s)
Anti-Bacterial Agents , Brain Diseases , Enterobacteriaceae Infections , Enterobacteriaceae , Humans , Aged , Male , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Enterobacteriaceae/isolation & purification , Brain Diseases/microbiology , Brain Diseases/drug therapy , Brain Diseases/diagnosis , Bacteremia/drug therapy , Bacteremia/microbiology , Bacteremia/diagnosis
11.
BMJ Case Rep ; 17(5)2024 May 03.
Article in English | MEDLINE | ID: mdl-38702069

ABSTRACT

A case of neonatal sepsis caused by Edwardsiella tarda, an uncommon pathogen typically associated with aquatic lifeforms, is described. The infant presented in septic shock with seizures and respiratory failure and was found to have meningitis, ventriculitis and a brain abscess requiring drainage. Only a small number of case reports of neonatal E. tarda infection, several with sepsis with poor auditory or neurodevelopmental outcomes or meningitis, have been described in the literature. This case report suggests that E. tarda, while uncommon, can be a cause of serious central nervous system disease in the neonatal population and that an aggressive approach to pursuing and treating complications may lead to improved neurodevelopmental outcomes.


Subject(s)
Brain Abscess , Cerebral Ventriculitis , Edwardsiella tarda , Enterobacteriaceae Infections , Neonatal Sepsis , Humans , Infant, Newborn , Anti-Bacterial Agents/therapeutic use , Brain Abscess/microbiology , Cerebral Ventriculitis/microbiology , Cerebral Ventriculitis/diagnosis , Cerebral Ventriculitis/drug therapy , Edwardsiella tarda/isolation & purification , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/complications , Enterobacteriaceae Infections/drug therapy , Meningitis/microbiology , Meningitis/diagnosis , Meningitis, Bacterial/microbiology , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/complications , Neonatal Sepsis/microbiology , Neonatal Sepsis/diagnosis
12.
Surg Infect (Larchmt) ; 25(4): 335-337, 2024 May.
Article in English | MEDLINE | ID: mdl-38696669

ABSTRACT

Background: Raoultella planticola is an uncommon gram-negative organism found in the environment. Patients and Methods: The patient, an 81-year-old female who had undergone total cystectomy and bilateral ureteral stoma surgery, presented to the hospital with a fever. It was determined that Raoultella planticola was responsible for the bacteremia. Results: Rapid identification of bacteria using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in blood culture samples and appropriate antibacterial treatment was begun and the patient was discharged three days later. Conclusions: This case emphasizes the presence of a rare pathogen as the cause of bacteremia and underscores the importance of utilizing rapid methods for bacterial identification to establish an accurate diagnosis.


Subject(s)
Anti-Bacterial Agents , Bacteremia , Blood Culture , Enterobacteriaceae Infections , Enterobacteriaceae , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Humans , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Female , Bacteremia/diagnosis , Bacteremia/microbiology , Aged, 80 and over , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Blood Culture/methods , Anti-Bacterial Agents/therapeutic use
13.
Microbiol Spectr ; 12(6): e0054224, 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38651878

ABSTRACT

The use of molecular identification panels has advanced the diagnosis for blood stream infections with fast turnaround time and high accuracy. Yet, this technology cannot completely replace conventional blood culture and standardized antibiotic susceptibility testing (AST) given its limitations and occasional false results. Here we present two cases of bacteremia caused by Kluyvera. Its identification and antibiotic resistance were at least partially mispresented by blood culture molecular identification panels on ePlex, Verigene, and Biofire. The detection of CTX-M resistance marker did not align with the susceptibility to the third generation cephalosporins among a wide range of antibiotics for this organism. Conventional extended-spectrum beta-lactamase (ESBL) testing was used to confirm the absence of ESBL. Caution should be taken when managing cases with CTX-M or ESBL detection in blood culture caused by uncommon pathogens. Conventional culture with microbial identification and standardized AST should continue to be the gold standard for routine patient care. IMPORTANCE: This is the first report that highlights the limitations of blood culture molecular identification panels on identifying Kluyvera and its associated antibiotic resistance patterns. Both the false identification and overreporting of antibiotic resistance could mislead the treatment for bacteremia caused by this pathogen. Patient isolation could have been avoided due to the lack of extended-spectrum beta-lactamase (ESBL) activity of the organism. This report emphasizes the importance of confirming rapid identification and antibiotic resistance by molecular technologies with standardized methods. It also provides insight into the development of new diagnostic panels.


Subject(s)
Anti-Bacterial Agents , Bacteremia , Blood Culture , Kluyvera , Microbial Sensitivity Tests , beta-Lactamases , Female , Humans , Male , Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , Bacteremia/diagnosis , Bacteremia/drug therapy , beta-Lactamases/genetics , Blood Culture/methods , Cephalosporins/pharmacology , Cephalosporins/therapeutic use , Diagnostic Errors , Drug Resistance, Bacterial/genetics , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Kluyvera/genetics , Kluyvera/drug effects , Kluyvera/isolation & purification , Aged, 80 and over
14.
BMC Infect Dis ; 24(1): 444, 2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38671365

ABSTRACT

INTRODUCTION: Carbapenemase-producing Enterobacterales (CPE) are an important public health threat, with costly operational and economic consequences for NHS Integrated Care Systems and NHS Trusts. UK Health Security Agency guidelines recommend that Trusts use locally developed risk assessments to accurately identify high-risk individuals for screening, and implement the most appropriate method of testing, but this presents many challenges. METHODS: A convenience sample of cross-specialty experts from across England met to discuss the barriers and practical solutions to implementing UK Health Security Agency framework into operational and clinical workflows. The group derived responses to six key questions that are frequently asked about screening for CPE. KEY FINDINGS: Four patient groups were identified for CPE screening: high-risk unplanned admissions, high-risk elective admissions, patients in high-risk units, and known positive contacts. Rapid molecular testing is a preferred screening method for some of these settings, offering faster turnaround times and more accurate results than culture-based testing. It is important to stimulate action now, as several lessons can be learnt from screening during the COVID-19 pandemic, as well as from CPE outbreaks. CONCLUSION: Further decisive and instructive information is needed to establish CPE screening protocols based on local epidemiology and risk factors. Local management should continually evaluate local epidemiology, analysing data and undertaking frequent prevalence studies to understand risks, and prepare resources- such as upscaled screening- to prevent increasing prevalence, clusters or outbreaks. Rapid molecular-based methods will be a crucial part of these considerations, as they can reduce unnecessary isolation and opportunity costs.


Subject(s)
Bacterial Proteins , Enterobacteriaceae Infections , Mass Screening , beta-Lactamases , Humans , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , England , beta-Lactamases/metabolism , beta-Lactamases/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Mass Screening/methods , Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Hospitals , COVID-19/diagnosis , SARS-CoV-2 , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/genetics
15.
Clin J Gastroenterol ; 17(3): 457-460, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38483783

ABSTRACT

We present the case of a male with end-stage diabetic nephropathy on haemodialysis who initially presented with acute-on-chronic digital ulceration. While awaiting vascular intervention, he became septic with abdominal pain and diarrhoea. Flexible sigmoidoscopy confirmed pseudomembranous colitis secondary to Clostridium difficile. Blood cultures grew Parabacteroides distasonis, a Gram-negative gut anaerobe. Enterobacter cloacae, another Gram-negative anaerobic gut bacilli, was grown in colonic cultures and swabs of the digital ulcers. We hypothesise that the pseudomembranous colitis increased gut translocation and thus led to the systemic spread of both gut anaerobes. This is the first reported case of Parabacteroides distasonis bacteraemia in the context of Clostridium difficile infection. Our patient recovered with antibiotics and went on to have vascular intervention for his digital ulceration.


Subject(s)
Bacteremia , Enterocolitis, Pseudomembranous , Humans , Male , Bacteremia/microbiology , Bacteremia/drug therapy , Bacteremia/diagnosis , Bacteremia/complications , Enterocolitis, Pseudomembranous/microbiology , Enterocolitis, Pseudomembranous/diagnosis , Anti-Bacterial Agents/therapeutic use , Bacteroidetes/isolation & purification , Diabetic Nephropathies/complications , Middle Aged , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/complications , Enterobacter cloacae/isolation & purification , Clostridioides difficile/isolation & purification , Renal Dialysis
16.
J Hosp Infect ; 148: 11-19, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38554809

ABSTRACT

BACKGROUND: Enterobacter cloacae complex (ECCO) comprises closely related Enterobacterales, causing a variety of infections ranging from mild urinary tract infections to severe bloodstream infections. ECCO has emerged as a significant cause of healthcare-associated infections, particularly in neonatal and adult intensive care. AIM: The Enterobacter Cloacae COMplex PASsive Surveillance (EC-COMPASS) aims to provide a detailed multi-centre overview of ECCO epidemiology and resistance patterns detected in routine microbiological diagnostics in four German tertiary-care hospitals. METHODS: In a sentinel cluster of four German tertiary-care hospitals, all culture-positive ECCO results between 1st January 2020 and 31st December 2022, were analysed based on Hybase® laboratory data. FINDINGS: Analysis of 31,193 ECCO datasets from 14,311 patients revealed a higher incidence in male patients (P<0.05), although no significant differences were observed in ECCO infection phenotypes. The most common sources of ECCO were swabs (42.7%), urine (17.5%), respiratory secretions (16.1%), blood cultures (8.9%) and tissue samples (5.6%). The annual bacteraemia rate remained steady at approximately 33 cases per hospital. Invasive ECCO infections were predominantly found in oncology and intensive care units. Incidences of nosocomial outbreaks were infrequent and limited in scope. Notably, resistance to carbapenems was consistently low. CONCLUSION: EC-COMPASS offers a profound clinical perspective on ECCO infections in German tertiary-healthcare settings, highlighting elderly men in oncology and intensive care units as especially vulnerable to ECCO infections. Early detection strategies targeting at-risk patients could improve ECCO infection management.


Subject(s)
Cross Infection , Enterobacter cloacae , Enterobacteriaceae Infections , Humans , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/diagnosis , Male , Female , Middle Aged , Aged , Enterobacter cloacae/isolation & purification , Germany/epidemiology , Adult , Cross Infection/epidemiology , Cross Infection/microbiology , Aged, 80 and over , Young Adult , Tertiary Care Centers/statistics & numerical data , Adolescent , Incidence , Epidemiological Monitoring , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Infant , Child , Child, Preschool , Bacteremia/epidemiology , Bacteremia/microbiology , Bacteremia/diagnosis , Infant, Newborn
17.
BMC Infect Dis ; 24(1): 363, 2024 Mar 29.
Article in English | MEDLINE | ID: mdl-38553710

ABSTRACT

BACKGROUND: In recent years, Raoultella ornithinolytica (R. ornithinolytica) have attracted clinical attention as a new type of pathogen. A wide range of infections with these germs is reported, and commonly found in urinary tract infections, respiratory infections, and bacteremia. CASE PRESENTATION: We report the case of an elderly woman with liver abscess, choledocholithiasis and cholangitis, who developed gastric fistula and abdominal abscess after underwent choledocholithotomy, and R. ornithinolytica were isolated from the abdominal drainage fluid. The patient was treated with meropenem and levofloxacin and had a good outcome. CONCLUSIONS: To the best of our knowledge, case of isolating R. ornithinolytica from a patient with non-viscerally abdominal abscess was extremely rare. We share a case of a woman with non-viscerally abdominal abscess secondary to postoperative gastric fistula, R. ornithinolytica was isolated from the patient's pus, and the pathogenic bacteria may originate from the gastrointestinal tract. Based on this case, We should be cautious that invasive treatment may greatly increase the probability of infection with this pathogenic bacterium.


Subject(s)
Enterobacteriaceae Infections , Gastric Fistula , Liver Abscess , Female , Humans , Aged , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/complications , Gastric Fistula/complications , Enterobacteriaceae , Postoperative Complications/drug therapy , Liver Abscess/complications
18.
J Hosp Infect ; 146: 93-101, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38369061

ABSTRACT

BACKGROUND: Carbapenemase-producing Enterobacterales (CPE) are of serious concern worldwide due to high morbidity and mortality. AIM: To evaluate the impact of the result of a subsequent polymerase chain reaction (PCR) test for carbapenemase after serial negative surveillance cultures on positive culture conversion in patients with three consecutive negative surveillance cultures for CPE, and to identify risk factors for conversion. METHODS: A retrospective study of patients with positive CPE cultures on CHROMagar KPC medium was performed in a Korean tertiary hospital from October 2018 to December 2022. PCR for blaKPC, blaNDM, blaIMP, blaVIM, blaGES, and blaOXA-48 was performed after three consecutive negative rectal swab cultures. Clinical characteristics and outcomes of patients were compared according to whether follow-up PCR was positive (CNPP) or negative (CNPN). FINDINGS: Of 1075 patients with positive CPE cultures, 150 (14.0%) yielded three consecutive negative rectal swab cultures. Of these, 50 (33.3%) were CNPP, and 100 (66.7%) were CNPN. Risk factors associated with a positive PCR result on multivariate analysis were: age, central venous catheter, and Escherichia coli infection. CNPP patients were more likely to have positive culture conversion for CPE than CNPN patients (39/44 (88.6%) vs 21/50 (42.0%), P<0.001). In multivariate analysis, independent risk factors for culture conversion were: a positive PCR result after surveillance cultures, diabetes mellitus, central venous catheter, and Klebsiella pneumoniae. CONCLUSION: CNPP patients have higher rates of culture conversion than CNPN patients, and a follow-up PCR test after serial negative surveillance cultures is useful in deciding whether or not to discontinue contact precautions.


Subject(s)
Enterobacteriaceae Infections , Humans , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/epidemiology , Retrospective Studies , beta-Lactamases/genetics , Bacterial Proteins/genetics , Klebsiella pneumoniae , Polymerase Chain Reaction , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use
19.
J Vet Diagn Invest ; 36(1): 124-127, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37919965

ABSTRACT

Carbapenemase-producing Enterobacterales (CPE) are one of the most urgent threats to human healthcare globally. Descriptions of CPE outbreaks in veterinary hospitals suggest the need for screening strategies for CPE from companion animals. Our aim was to optimize a chromogenic agar method with and without selective enrichment to isolate CPE from companion animal feces in an ongoing outbreak of New Delhi metallo-ß-lactamse-5 Escherichia coli. A limit of detection (LOD) assay for spiked canine and feline feces was performed for both methods using a carbapenamase-producing E. coli (24213-18); the LOD (1.5 × 103 cfu/g of feces) was equivalent to that reported for human fecal specimens. We screened 1,247 companion animal fecal specimens for carriage of CPE by 1) direct plating to chromogenic agar and 2) plating to chromogenic agar following selective enrichment. Twenty-one specimens were positive for CPE by both direct culture and enrichment culture. No specimens were positive with selective enrichment and negative by direct culture. A selective enrichment step did not result in any increased recovery of CPE from companion animals, which suggests that enrichment broth may not be necessary for outbreak surveillance testing. It is important to continue to validate methods for the detection of CPE in companion animals as outbreaks become more common in veterinary facilities.


Subject(s)
Cat Diseases , Dog Diseases , Enterobacteriaceae Infections , Animals , Cats , Dogs , Humans , Escherichia coli , Enterobacteriaceae , Agar , Cat Diseases/diagnosis , Cat Diseases/epidemiology , Bacteriological Techniques/veterinary , Bacteriological Techniques/methods , Dog Diseases/diagnosis , Dog Diseases/epidemiology , Bacterial Proteins , Disease Outbreaks/veterinary , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/veterinary , Microbial Sensitivity Tests/veterinary
20.
Microbiol Spectr ; 12(1): e0317223, 2024 Jan 11.
Article in English | MEDLINE | ID: mdl-38054723

ABSTRACT

IMPORTANCE: Enteric bacterial infections caused by Salmonella, Shigella, pathogenic Escherichia coli, and Campylobacter represent one of the most common causes of infectious enteritis worldwide. The timely and accurate diagnosis of pathogens causing gastroenteritis is crucial for patient care, public health, and disease surveillance. While stool culture has long been the standard and highly specific method for detecting enteric pathogens, it is labor-intensive and time-consuming with limited sensitivity. To improve patient outcomes, there is a need to implement new cost-effective approaches for the detection of bacterial enteric pathogens with higher sensitivity and faster time to result. This study shows that multiplex real-time polymerase chain reaction-based tests, such as the TAQPATH Enteric Bacterial Select Panel, are accurate and cost-effective diagnostic alternatives for the detection and differentiation of the most common enteric bacterial pathogens, offering quicker time to result and higher sensitivity compared to routine stool culture.


Subject(s)
Enterobacteriaceae Infections , Enterobacteriaceae , Humans , Enterobacteriaceae/genetics , Salmonella , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/microbiology , Bacteria/genetics , Escherichia coli , Feces/microbiology , Diagnostic Tests, Routine , Diarrhea/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL